Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research
In Brief: Upton Still Pondering Location Of Centers, Other Program; Moves Could Involve DCCR
Successful Treatment by Community MDs Reducing Numbers Of Patients In Research, DCT Board Told; “We can Work With them,” Carbone Says
DCCR Community Oncology Program RFP Now Ready
NCI Statisticians Disputes Bross Claim
Pauling Contends His Applications Included Essentials
Rall, FDA Chief On AACR Panel
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”